Shifting Focus in Autoimmune Diseases

Oct 20, 05:39 PM

Headliner
Share
Subscribe

Artax Biopharma’s CEO Rob Armstrong explains recent shifts in autoimmune R&D before discussing his leadership style.

Share
Subscribe
Next
Pharmaceutical Executive Daily: FDA's National Priority Voucher Program
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive